Harrow Analyst Price Targets - Benzinga

SPY776.41+0.32%QQQ749.64+0.28%BTC/USD83,199.36+1.84%DIA513.22+0.31%GLD384.22+1.48%TLT77.62−0.32%

Harrow Inc

HROWNASDAQ

Trade with Public

Trade with Public

$29.49

-1.03-3.38%

Last update: Oct 9, 10:19 AM

$31.30

0.782.56%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Harrow Analyst Price Targets

Wall Street analyst price targets and consensus rating for Harrow (HROW).

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$60Upside to Avg. PT+104.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	BTIG	Thomas Shrader	Maintained	Buy	$63
Sep 9, 2026	Leerink Partners	Daniel Clark	Initiate	Outperform	$45
Aug 11, 2026	BTIG	Thomas Shrader	Maintained	Buy	$63
Jul 21, 2026	BTIG	Thomas Shrader	Maintained	Buy	$63
May 13, 2026	Cantor Fitzgerald	Steve Seedhouse	PT Cut	Overweight	$91→$88
May 12, 2026	BTIG	Thomas Shrader	Maintained	Buy	$63
Apr 17, 2026	BTIG	Thomas Shrader	Maintained	Buy	$63
Apr 7, 2026	B. Riley Securities	Mayank Mamtani	PT Cut	Buy	$74→$65
Mar 19, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$70
Mar 18, 2026	BTIG	Thomas Shrader	Maintained	Buy	$63
Mar 4, 2026	Cantor Fitzgerald	Steve Seedhouse	PT Cut	Overweight	$94→$91
Mar 4, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$69→$70
Nov 12, 2025	Ladenburg Thalmann	Jeffrey Cohen	PT Raise	Buy	$64→$66
Nov 12, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$64→$69
Oct 1, 2025	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$70→$74
Sep 29, 2025	Lake Street	Thomas Flaten	PT Raise	Buy	$42→$70
Sep 29, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$64
Sep 29, 2025	BTIG	Thomas Shrader	Maintained	Buy	$63
Sep 24, 2025	BTIG	Thomas Shrader	Maintained	Buy	$63
Sep 23, 2025	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$65→$70

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on Harrow, Maintains $63 Price Target

BTIG analyst Thomas Shrader reiterates Harrow (NASDAQ:HROW) with a Buy and maintains $63 price target.

Benzinga Newsdesk

PRO
Leerink Partners Initiates Coverage On Harrow with Outperform Rating, Announces Price Target of $45

Leerink Partners analyst Daniel Clark initiates coverage on Harrow (NASDAQ:HROW) with a Outperform rating and announces Price Target of $45.

Benzinga Newsdesk

Harrow’s Iheezo Cuts Eye-Injection Discomfort by More Than Half

Harrow (NASDAQ: HROW) posts positive study results for IHEEZO ophthalmic gel, significantly reducing IVT injection patient discomfort.

Vandana Singh

PRO
BTIG Reiterates Buy on Harrow, Maintains $63 Price Target

BTIG analyst Thomas Shrader reiterates Harrow (NASDAQ:HROW) with a Buy and maintains $63 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Harrow, Maintains $63 Price Target

BTIG analyst Thomas Shrader reiterates Harrow (NASDAQ:HROW) with a Buy and maintains $63 price target.

Benzinga Newsdesk

Harrow Adds Another Piece To Ophthalmology Strategy

Harrow relaunches Verkazia for VKC treatment, targeting pediatric eye disease with a steroid-sparing therapy option.

Vandana Singh